[1] |
Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015[J]. CA Cancer J Clin, 2016, 66(2):115-132.
|
[2] |
Howlader N, Noone AM, Krapcho M, et al. SEER Cancer Statistics Review, 1975-2014[R/OL]. Bethesda (MD): National Cancer Institute. 2017[2018-09-20].https://seer.cancer.gov/csr/1975_2014/.
|
[3] |
Miller KD, Siegel RL, Lin CC, et al. Cancer treatment and survivorship statistics, 2016[J]. CA Cancer J Clin, 2016, 66(4):271-289.
|
[4] |
Higuchi M, Yaginuma H, Yonechi A, et al. Long-term outcomes after video-assisted thoracic surgery(VATS) lobectomy versus lobectomy via open thoracotomy for clinical stage IA non-small cell lung cancer[J]. J Cardiothorac Surg, 2014, 9:88.
|
[5] |
New York Early Lung Cancer Action Project Investigators. CT Screening for lung cancer: diagnoses resulting from the New York Early Lung Cancer Action Project[J]. Radiology, 2007, 243(1):239-249.
|
[6] |
Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015[J]. CA Cancer J Clin, 2015, 65(1):5-29.
|
[7] |
Patz EF Jr, Greco E, Gatsonis C, et al. Lung cancer incidence and mortality in National Lung Screening Trial participants who underwent low-dose CT prevalence screening: a retrospective cohort analysis of a randomised, multicentre, diagnostic screening trial[J]. Lancet Oncol, 2016, 17(5):590-599.
|
[8] |
望云, 范丽, 周莹, 等. 上海地区低剂量CT筛查肺癌基线初步报告[J]. 中华健康管理学杂志, 2018, 12(1):51-54.
|
[9] |
National Lung Screening Trial Research Team, Church TR, Black WC, et al. Results of initial low-dose computed tomographic screening for lung cancer[J]. N Engl J Med, 2013, 368(21):1980-1991.
|
[10] |
Field JK, Duffy SW, Baldwin DR, et al. UK Lung Cancer RCT Pilot Screening Trial: baseline findings from the screening arm provide evidence for the potential implementation of lung cancer screening[J]. Thorax, 2016, 71(2):161-170.
|
[11] |
Infante M, Cavuto S, Lutman FR, et al. Long-Term Follow-up Results of the DANTE Trial, a Randomized Study of Lung Cancer Screening with Spiral Computed Tomography[J]. Am J Respir Crit Care Med, 2015, 191(10):1166-1175.
|
[12] |
Horeweg N, Scholten ET, de Jong PA, et al. Detection of lung cancer through low-dose CT screening (NELSON): a prespecified analysis of screening test performance and interval cancers[J]. Lancet Oncol, 2014, 15(12):1342-1350.
|
[13] |
高忠嵩, 叶兆祥, 张鹏, 等. 天津地区低剂量CT肺癌基线筛查与随访的初步临床分析[J]. 中国肿瘤临床, 2017, 44(20):1034-1039.
|
[14] |
周清华, 范亚光, 王颖, 等. 中国肺癌低剂量螺旋CT筛查指南(2018年版)[J]. 中国肺癌杂志, 2018, 21(2):67-75.
|
[15] |
Horeweg N, van Rosmalen J, Heuvelmans MA, et al. Lung cancer probability in patients with CT-detected pulmonary nodules: a prespecified analysis of data from the NELSON trial of low-dose CT screening[J]. Lancet Oncol, 2014, 15(12):1332-1341.
|
[16] |
Pastorino U, Rossi M, Rosato V, et al. Annual or biennial CT screening versus observation in heavy smokers: 5-year results of the MILD trial[J]. Eur J Cancer Prev, 2012, 21(3):308-315.
|
[17] |
Snoeckx A, Reyntiens P, Desbuquoit D, et al. Evaluation of the solitary pulmonary nodule: size matters, but do not ignore the power of morphology[J]. Insights Imaging, 2018, 9(1):73-86.
|
[18] |
Walter JE, Heuvelmans MA, de Jong PA, et al. Occurrence and lung cancer probability of new solid nodules at incidence screening with low-dose CT: analysis of data from the randomised, controlled NELSON trial[J]. Lancet Oncol, 2016, 17(7):907-916.
|